EXPO

EXPONENT INC. - 10-Q Filing Summary

Business Context and Reporting Period

Company: Exponent, Inc. (EXPO)
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Three and nine months ended October 3, 2025
Business Overview: Exponent is an engineering and scientific consulting firm providing solutions to complex problems across more than 90 technical disciplines. The company operates two reportable segments: Engineering & Other Scientific, and Environmental and Health.

Key Financial Metrics

Liquidity & Debt: The company reported no long-term debt. Total liabilities were $358.6 million as of October 3, 2025, primarily consisting of deferred compensation plan liabilities ($123.1 million) and operating lease liabilities ($82.6 million). Cash and cash equivalents decreased by $51.5 million during the nine-month period, largely due to financing activities.

Material Changes vs. Prior Period

• Revenue Growth: Q3 2025 revenue increased 8.0% year-over-year (YoY), driven by a 10% increase in revenues before reimbursements. The Engineering & Other Scientific segment grew 7.6%, while Environmental and Health grew 9.8%.
• Profitability: Q3 Net Income increased 8% YoY. However, for the nine-month period, Net Income decreased 4.9% ($81.2M vs $85.4M) and Operating Income decreased 1.8% ($90.6M vs $92.3M).
• Expense Increases: General and Administrative (G&A) expenses rose 44.2% in Q3 and 10.7% for the nine months, primarily due to a company-wide managers' meeting in Q3 2025 (not held in 2024) and higher travel costs. Other operating expenses increased 9.3% for the nine months, partly due to a $2.0 million non-cash rent expense increase from a land lease extension in Arizona.
• Share Repurchases: The company significantly increased buyback activity, repurchasing $72.7 million of common stock in the first nine months of 2025 compared to $5.7 million in the same period in 2024.

Guidance, Outlook, and Risks

Management Commentary: Management attributes Q3 growth to increasing demand for dispute-related work in energy, transportation, life sciences, and construction sectors. Proactive engagements were led by risk management in utilities and regulatory consulting in chemicals. The company remains focused on capitalizing on emerging growth areas and enhancing stockholder value through dividends and share repurchases.

Subsequent Events: On October 30, 2025, the Board declared a quarterly dividend of $0.30 per share (payable Dec 19, 2025) and authorized an additional $100 million for share repurchases.

Risks & Contingencies:

• Legal: The company is a party to various legal actions but believes the outcome will not have a material adverse effect.
• Market Risk: Exposure to interest rate fluctuations on cash equivalents and foreign currency exchange rate risks (GBP, HKD, CNY, SGD). The company does not use derivatives to hedge these risks.
• Operational: Risks include demand declines due to economic conditions, competitive pricing, and the ability to attract/retain key employees.

Investor Verification Checklist

• Revenue Quality: Verify the sustainability of the 10% growth in "Revenues before reimbursements" versus the 8% total revenue growth, noting the mix of time-and-materials (79%) vs. fixed-price (21%) contracts.
• Expense Volatility: Assess the impact of the one-time company-wide managers' meeting on G&A expenses and determine if future quarters will normalize.
• Deferred Compensation Impact: Review the volatility in "Other income, net" and "Compensation expenses" driven by the fair value changes of the deferred compensation plan assets ($7.0M gain in Q3).
• Cash Flow Usage: Confirm the sustainability of the aggressive share repurchase program ($72.7M in 9M) alongside dividend payments ($46.7M in 9M) given the $51.5M reduction in cash reserves.
• Lease Obligations: Monitor the long-term impact of the Arizona land lease extension, which increases annual rent obligations starting in 2028.